February 22, 2017 / 9:38 AM / 5 months ago

BRIEF-NeuroVive enters research agreements in NASH and hepatocellular carcinoma

1 Min Read

Feb 22 (Reuters) - NeuroVive Pharmaceutical Ab:

* Says appoints recognized scientific advisors and enters research agreements in NASH and hepatocellular carcinoma Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below